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Abstract
Background: During the menstrual cycle, the ovarian steroid hormones estrogen and progesterone control a dramatic
transcriptional reprogramming of endometrial stromal cells (ESCs) leading to a receptive state for blastocyst implantation
and the establishment of pregnancy. A key marker gene of this decidualization process is the prolactin gene. Several
transcriptional regulators have been identified that are essential for decidualization of ESCs, including the Hox genes HoxA-
10 and HoxA-11, and the forkhead box gene FOXO1A. While previous studies have identified downstream target genes for
HoxA-10 and FOXO1A, the role of HoxA-11 in decidualization has not been investigated. Here, we show that HoxA-11 is
required for prolactin expression in decidualized ESC. While HoxA-11 alone is a repressor on the decidual prolactin
promoter, it turns into an activator when combined with FOXO1A. Conversely, HoxA-10, which has been previously shown
to associate with FOXO1A to upregulate decidual IGFBP-1 expression, is unable to upregulate PRL expression when co-
expressed with FOXO1A. By co-immunoprecipitation and chromatin immunoprecipitation, we demonstrate physical
association of HoxA-11 and FOXO1A, and binding of both factors to an enhancer region (2395 to 2148 relative to the PRL
transcriptional start site) of the decidual prolactin promoter. Because FOXO1A is induced upon decidualization, it serves to
assemble a decidual-specific transcriptional complex including HoxA-11. These data highlight cooperativity between
numerous transcription factors to upregulate PRL in differentiating ESC, and suggest that this core set of transcription
factors physically and functionally interact to drive the expression of a gene battery upregulated in differentiated ESC. In
addition, the functional non-equivalence of HoxA-11 and HoxA-10 with respect to PRL regulation suggests that these
transcription factors regulate distinct sets of target genes during decidualization.
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Introduction
The successful establishment of pregnancy is dependent on
proper growth and development of the uterine endometrium in
preparation for blastocyst implantation. This complex process
involves secretory transformation of glandular epithelial cells
followed by decidualization of stromal cells [1]. The process of
decidualization is poorly understood at the molecular level, but a
key stimulus is progesterone acting on estrogen-primed endome-
trial stromal cells (ESCs) leading to dramatic transcriptional
reprogramming [2]. Among the numerous genes that are
upregulated during decidualization, prolactin (PRL) is one of the
most dramatically induced, and decidua-derived PRL is one of the
most abundant secretory products in the amniotic fluid [1,3–6].
In the event of successful pregnancy, PRL expression in
decidualized endometrial stromal cells persists until parturition
[7–9]. Numerous functions are ascribed to decidual PRL including
regulation of epithelial cell differentation, trophoblast growth,
angiogenesis and modulation of the immune system [1,4]. In
rodents, an important role for decidual PRL is the suppression of
genes detrimental to pregnancy, such as the cytokine interleukin-6
and the steroidogenic enzyme 20a-hydroxysteroid dehydrogenase
[3,10,11]. Thus, the proper regulation of decidual PRL is essential
for implantation and pregnancy.
In humans, decidual PRL is transcribed from an alternative
promoter located upstream of the non-coding exon 1a, approximately
6 kb upstream of the promoter driving PRL expression in the pituitary
from exon 1b [12]. Utilization of the alternative promoter ensures
tissue-specific regulation of PRL transcription, while the protein
encoded by the decidua- and the pituitary-specific transcripts is
identical [12,13]. The decidual PRL (dPRL) enhancer/promoter
region is composed of two transposable elements in humans, MER20
and MER39 [13]. The eutherian-specific MER20 is located at 2395/
2148 relative to the transcriptional start site of the decidual transcript
and contains binding sites for CCAAT/enhancer-binding protein b
(C/EBPb) [14,15] and FOXO1A [14,16,17]. An essential ETS1
binding site [18,19] and a CREB site [20,21] is found in the primate-
specific MER39 that also encodes exon 1a.
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sites for abdominal-B (Abd-B) related Hox proteins (Hox paralog
groups 9–13; this study). Expression of the Abd-B related HoxA
genes HoxA-10 and HoxA-11 along the paramesonephric
(Mu ¨llerian) duct is essential for the development and function
of the female reproductive tract [22]. These genes continue to be
expressed in the adult uterus and are required for successful
blastocyst implantation in the mouse [23–26] suggesting that
they play an active role in the regulation of decidual gene
expression.
We previously observed a cooperative interaction of HoxA-11
with FOXO1A in regulating decidual PRL expression [27]. In this
study we further characterize the ability of HoxA-11 to activate
decidual PRL expression using siRNA-mediated knockdown,
HoxA-11 overexpression and reporter gene assays. The results
indicate that HoxA-11 is an intrinsic repressor of PRL expression
but when combined with FOXO1A switches to a potent activator.
Based on our own and published knockout, knockdown, functional
and physical interaction data, we infer a decidual-specific
enhanceosome that potentially regulates a battery of genes
involved in endometrial differentiation such as PRL.
Results
Identification of transcription factor binding sites in the
dPRL enhancer
Several transcription factors essential for dPRL expression have
been identified, including FOXO1A which has functional binding
sites in the dPRL enhancer [14]. Interestingly, FOXO1A has been
shown to bind HoxA-10 [31], suggesting other Hox genes may
play a direct role in regulating PRL expression and cooperation
between FOXO1A and HoxA-11 has been observed to regulating
dPRL expression [27], suggested a direct role for Hox genes in
regulating dPRL expression. To identify potential Hox binding
sites in the dPRL enhancer, we searched the human dPRL
enhancer (chr6:22,411,225-22,411,422) with TRANSFAC for
high-scoring transcription factor binding site matches (.0.90 core
match identity). In addition to the previously known C/EBPb,
FOXO1A and ETS1 sites, three potential Hox binding sites were
identified in the dPRL enhancer, as well as binding sites for
nuclear factor KappaB (NFkB) subunit c-Rel, TG-interacting
factor (TGIF), CAAT displacement protein (CDP) and the
ubiquitous cofactor Oct-1 (Fig. 1).
HoxA-11 is necessary, but not sufficient, for PRL
expression
To determine if HoxA-11 was necessary for induction of PRL
expression, we transfected differentiating human endometrial
stromal cells (hESC) with two siRNAs targeting different sites of
the human HoxA-11 mRNA. In untransfected hESC, PRL
expression was induced over 100-fold 48 hr after differentiation
with cAMP analog and the progesterone analog medroxyproges-
terone acetate (MPA), while the HoxA-11 mRNA level remained
unchanged (Fig. 2). Transfection with HoxA-11 specific siRNAs
markedly reduced both HoxA-11 (.70% reduction) and PRL
(.70% reduction) expression in differentiated cells, while
transfection with a random sequence control siRNA (siRNA-Co)
led to a small enhancement of both HoxA-11 and PRL expression
(20–30% increase). Further experiments indicated that treatment
of hESC with transfection agents alone can induce both HoxA-11
and PRL expression (data not shown).
While the siRNA-mediated knockdown indicated that HoxA-11
is necessary for expression of PRL in decidual cells, most Hox
genes exert their effects though associations with cofactors and
transcription factors that impart activator or repressor functions
[28,29]. To identify if HoxA-11 alone is sufficient to induce PRL
expression, we overexpressed HoxA-11 in undifferentiated and
differentiated hESC and measured PRL expression. Overexpres-
sion of HoxA-11 had no effect on PRL expression in undifferen-
tiated hESC, while overexpression of HoxA-11 in differentiated
hESC led to a marked increase in PRL expression (6-fold) relative
to PRL expression in differentiated hESC transfected with empty
expression vector alone (Fig. 3). These results indicate that a
hormone-inducible cofactor is required for HoxA-11 mediated
activation of decidual PRL.
HoxA-11 functionally interacts with FOXO1A
Examination of the decidual PRL enhancer identified several
potential Hox binding sites, including one immediately adjacent to
FOXO1A and ETS1 binding sites (Fig. 1). Furthermore,
FOXO1A is upregulated both in vivo and in vitro upon
decidualization [6,14], suggesting that HoxA-11 and FOXO1A
may interact to regulate decidual PRL expression. To test if there
was a functional association of HoxA-11 and FOXO1A we
cotransfected HeLa cells with a luciferase reporter construct
containing the dPRL enhancer (dPRL-332/luc3) and expression
vectors for HoxA-11, FOXO1A or both (Fig. 4). Transfection of
HoxA-11 alone repressed expression of luciferase from the
decidual PRL enhancer, consistent with the finding that HoxA-
11 generally functions as a repressor [32]. Transfection of
FOXO1A alone had no effect on luciferase expression, while
transfection of both HoxA-11 and FOXO1A lead to over 3-fold
activation from the PRL enhancer (Fig. 4). These data suggest that
HoxA-11 and FOXO1A act cooperatively to upregulate PRL
from the decidual PRL enhancer, and that association with
FOXO1A switches HoxA-11 from a repressor to an activator.
HoxA-11 and HoxA-10 are not functionally equivalent
regulators of PRL expression
Previous studies have shown that HoxA-10 functionally and
physically interacts with FOXO1A to regulate decidual IGFBP-1
expression [30,31]. However, gene expression profiling in peri-
implantation mouse uterus did not identify PRL as a HoxA-10
target gene. These results suggest that although both HoxA-11 and
HoxA-10 can physically and functionally associate with FOXO1A,
their regulatory effects are target gene specific. To test if HoxA-10
Figure 1. Structure of the decidual PRL (dPRL) enhancer. Schematic of transcription factor binding sites in the MER20 dPRL enhancer. The
region 2395 to 2148 relative to the transcriptional start site, which corresponds to the MER20 transposon is shown. Binding sites for activators are
shown in green and for repressors in red. Oct-1 sites are shown as gray hexagons.
doi:10.1371/journal.pone.0006845.g001
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similar way as HoxA-11, we cotransfected HeLa cells with the
dPRL-332/luc3 luciferase reporter construct and expression
vectors for HoxA-10, and both HoxA-10 and FOXO1A (Fig. 4).
Like HoxA-11, HoxA-10 alone represses expression from the
dPRL-332/luc3 luciferase reporter construct. Remarkably, how-
ever, while co-expression of HoxA-11 and FOXO1A upregulates
expression from the dPRL enhancer, co-expression of HoxA-10
and FOXO1A failed to upregulate expression from the dPRL
enhancer. These results indicate that these Hox genes are
functionally non-equivalent with respect to their ability to regulate
decidual PRL expression, even though they are able to associate
with similar cofactors.
Identification of HoxA-11/FOXO1A binding sites
To identify the Hox and FOXO responsive region in the dPRL
enhancer, we cotransfected HeLa cells with luciferase reporter
constructs containing deletion mutants of the dPRL enhancer
(dPRL-332/luc3, dPRL-270/luc3, dPRL(2332/2232)/232/
luc3, and dPRL(2332/2270)/232/luc3) and expression vectors
for HoxA-11 and FOXO1A (Fig. 5). Deletion of the previously
characterized cluster of two C/EBP and a FOXO site (reporter
construct dPRL-270/luc3) reduced luciferase expression by ,50%
(Fig. 5), reflecting the previously reported cooperativity between
FOXO1A and C/EBP [13]. Deletion of the adjacent Hox/FOXO
sites (reporter construct dPRL(2332/2232)/232/luc3) reduced
luciferase expression by ,60% and deletion of the entire ETS/
Hox/FOXO binding site complex (construct dPRL(2332/
2270)/232/luc3) reduced luciferase expression by ,80% of the
full-length dPRL enhancer (Fig. 5). Similarly, mutating the Hox
site (TTATRGCGC) reduced luciferase expression by ,80% of
the full-length dPRL enhancer (Fig. 5).
HoxA-11 and FOXO1A physically interact
The functional association between HoxA-11 and FOXO1A
and their adjacent binding sites suggests they physically interact.
This was investigated by in vivo co-immunoprecipitation assays.
HeLa cells were transfected with a HoxA11-V5/His fusion protein
and either empty pcDNA3.1(+) vector or Flag-FOXO1A
pcDNA3.1. Immunoprecipitation was performed with anti-FLAG
agarose beads and assayed by serial western blot using anti-V5-
HRP and anti-Flag-HRP antibodies. HoxA11-V5/His was
immunoprecipitated in the presence of Flag-FOXO1A (Fig. 6),
but not controls indicating direct interaction between HoxA-11
and FOXO1A. Moreover, addition of DNase did not disrupt the
interaction, indicating that the physical interaction between
HoxA-11 and FOXO1A is not DNA-dependent (Fig. 6).
Chromatin Immunoprecipitation (ChIP)
To test if FOXO1A and HoxA-11 bind the dPRL enhancer in
vivo, we performed chromatin immunoprecipitation (ChIP) on
differentiated hESC followed by quantitative PCR to assay for the
PRL MER20 with primers designed to amplify the region from
2212 to 2270. We found significant enrichment of HoxA-11 and
FOXO1A on the dPRL enhancer in differentiated hESC
compared to controls precipitated with control IgG (Fig. 7).
Similarly, there was significant enrichment for C/EBPb, which
has been previously shown to bind the dPRL enhancer, and p300,
Figure 2. Effect of HoxA-11 knockdown on intrinsic HoxA-11 and PRL mRNA expression. The expression of PRL (dark gray bars) and
HoxA-11 (light gray bars) was assayed in undifferentiated, mock-transfected ESC (UnDiff), or in differentiated cells (Diff) that had not been transfected
(No Treat.) or had been transfected with random sequence siRNA control (siRNA-Co), or with two different siRNAs targeting HoxA-11 (siRNA-1, siRNA-
2). Results are shown as fold changes relative to expression levels in differentiated control cells (set to 1). n=6 replicate experiments, means6SEM. *,
P,0.05; ***, P,0.001 (t-test compared to No Treat.).
doi:10.1371/journal.pone.0006845.g002
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minor but still significant enrichment for Pol-II, and no
enrichment for YY1 (Fig. 7).
Discussion
Hox proteins are transcription factors that play important roles
in embryonic development and adult function of many tissues and
organ systems. In the female reproductive tract, the Abd-B related
Hox genes (Hox9-Hox13) are expressed along the developing
paramesonephric (Mu ¨llerian) duct and continue to be expressed in
adults. While many Hox genes are functionally redundant between
paralog group members, the Adb-B related HoxC and HoxD
genes regulate endometrial proliferation and HoxA genes regulate
endometrial differentiation and are required for successful
blastocyst implantation [23,24], suggesting the distinct roles of
these transcription factors is mediated by differential activation of
downstream target genes. Thus, identification of Hox target genes
is important for understanding their roles in endometrial function;
however, only three direct target genes of HoxA-10, namely
IGFBP1 [30,31], ITB3 [33] and EMX2 [34], and thus far no
targets of HoxA-11 have been identified in the endometrium.
By siRNA-mediated knockdown, overexpression, and deletion
analysis of the dPRL enhancer, we identified HoxA-11 as a direct
regulator of PRL expression. This adds HoxA-11 to the list of
transcription factors that are directly involved in dPRL activation,
such as AP-1 [35], C/EBPb [14,15], ETS1 [18,19], FOXO1A
[14,16,17] and PGR [36,37]. These results indicate that PRL
expression in the endometrium is a tightly regulated process that is
dependent on the coordinated action of multiple transcription
factors, which likely acts to canalize decidualization stimuli and
ensure inappropriate differentiation does not result from low level
or erroneous stimulation of stromal cells.
ChIP analysis of the dPRL enhancer in differentiated stromal
cells demonstrated that HoxA-11 and FOXO1A associate with the
dPRL enhancer, likely as part of an enhancer complex that
includes p300, C/EBPb and possibly Pol-II. Interestingly, previous
work has demonstrated that a composite C/EBPb/FOXO1A site
upstream of the HoxA-11/FOXO1A site binds C/EBPb and
FOXO1A, which recruit PGR to the enhancer [36,37]. These
results suggest that proteins bound to the C/EBPb/FOXO1A and
HoxA-11/FOXO1A composite sites may directly interact through
DNA-bending or looping, or that other cofactors bridge these two
protein complexes.
Several of the transcription factors with conserved binding-sites
in the decidual PRL enhancer have been characterized with
respect to endometrial function through knockout and knockdown
studies. For example, female HoxA-11 knockout mice are infertile
with specific defects in blastocyst attachment and implantation
[23,24], and knockout of C/EBPb impairs decidual differentiation
[38]. In human ESC, knockdown of ETS1 significantly reduces
PRL expression [18,19] and FOXO1A [16,17]. C/EBPb [14,15],
FOXO1A [14] and AP-1 [35] have also been demonstrated to
bind sites within the enhancer and are required for dPRL
expression.
Our work highlights the role of FOXO1A, a transcription factor
up-regulated in decidualization, to switch the constitutively
expressed repressor HoxA-11 to a potent co-activator. Further-
more, HoxA-10, which can also interact with FOXO1A is not able
to upregulate PRL expression. Together these data further
underpin the concept that multiple, but specific, transcription
factors function cooperatively to upregulate PRL in differentiating
Figure 3. Effect of HoxA-11 overexpression on PRL expression. The expression of PRL mRNA was assayed after overexpression of HoxA-11 in
undifferentiated (light gray bars) and differentiated (dark gray bars) ESC. Results are shown as fold changes relative to PRL expression in
undifferentiated and differentiated mock-transfected cells, respectively. HoxA-11 expression was confirmed in undifferentiated (light gray bars) and
differentiated (dark gray bars) ESC. HoxA-11 enhanced upregulation of PRL only in differentiated cells. Note, the y-axis (fold change) is log-scale.n=6
replicate experiments, means6SEM. ***, P,0.001 (t-test, overexpression compared to undifferentiated and differentiated, respectively).
doi:10.1371/journal.pone.0006845.g003
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physically and functionally interact to drive the expression of a
gene battery upregulated in differentiated ESC. Remarkably, there
are over 20,000 MER20s in the human genome and many located
near genes expressed in differentiated stromal cells (unpublished
observations: V.J. Lynch, R. Leclerc, and G.P. Wagner). If
Figure 5. Identification of the HoxA-11/FOXO1A responsive region of the dPRL promoter. The expression of luciferase was assayed in
HeLa cells transiently transfected with HoxA-11 and FOXO1A and (from top to bottom) either dPRL-332/luc3, dPRL-270/luc3, dPRL(2332/2232)/232/
luc3, dPRL(2332/2270)/232/luc3, dPRL-32/luc3 or dPRL-332/luc3mutHox. Results are shown as fold changes relative to luciferase expression in cells
cotransfected with HoxA-11/FOXO1A and dPRL-332/luc3. A schematic of the location of transcription factor binding sites and deletions is shown.
n=6 replicate experiments, means6SEM. ***, P,0.001 (t-test compared to dPRL-332/luc3).
doi:10.1371/journal.pone.0006845.g005
Figure 4. HoxA-11 and FOXO1A functionally cooperate to upregulate PRL expression. The expression of luciferase was assayed in HeLa
cells transiently transfected with the dPRL-332/luc3 decidual PRL enhancer reporter construct, cotransfected with either empty expression vector,
HoxA-11 alone, HoxA-10 alone, FOXO1A alone, or FOXO1A cotransfected with either HoxA-11 or HoxA-10. Results are shown as fold changes relative
to luciferase expression in cells cotransfected with dPRL-332/luc3 and empty expression vector. n=8 replicate experiments, means6SEM. **, P,0.05;
***, P,0.001 (t-test compared to empty vector).
doi:10.1371/journal.pone.0006845.g004
Cooperative Regulation of PRL
PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e6845transcription factor binding is a general feature of MER20s,
particularly by FOXO1A, HoxA-11, CEBPb and p300, then
MER20 derived regulatory elements may be orchestrators of ESC
differentiation.
Methods
Identification of transcription factor binding sites in the
dPRL enhancer
Potential transcription factor binding sites in the human
MER20-derived decidual PRL enhancer (dPRL) were identified
using the MATCH program (http://www.gene-regulation.com/)
utilizing TRANSFAC binding site matrices with a match cut-off
selected to minimize the sum of false positive and false negative
results. Only binding site matches with .90% identity to the core
binding site motif are reported here.
Reporter constructs and expression vectors
Generation of the dPRL promoter/luciferase reporter constructs
in the pGL3-Basic plasmid (Promega) has been described [12].
Briefly, construct dPRL-332/luc3 contains the wild type dPRL
promoter sequence 2332 to +65 relative to the human dPRL
transcriptional start site [12]. Similarly, the dPRL-270/luc3 construct
contains 2270 to +65 relative to the human dPRL transcriptional
start site, and dPRL-32/luc3 encompasses the minimal dPRL
promoter element (232 to +65). The internal deletion constructs
dPRL(2332/2270)/232/luc3 and dPRL(2332/2232)/232/luc3
were generated by placing the elements 2332/2270 or 2332/
2232, respectively, immediately upstream of the minimal dPRL
promoter element in dPRL-32/luc3. The dPRL-332luc3mutHox
construct mutated the Hoxbinding sitespanning2232to2236 from
TTAT to GCGC using the QuickChange site directed mutagenesis
kit (Stratagene, Texas USA).
The full-length human HoxA-11 and HoxA-10 cDNAs were
cloned into the pcDNA3.1/V5-His Topo TA expression vector
(Invitrogen) to create HoxA11-V5/His and HoxA10-V5/His
fusion proteins, respectively. N-terminal Flag tagged human
FOXO1A was purchased from Addgene (Addgene plasmid
13507).
Cell culture and transient transfection
Human endometrial stromal cells immortalized with telomerase
(ATCC, Cat. No. CRL-4003) and HeLa cells were grown in
steroid-depleted DMEM, supplemented with 5% charcoal-
stripped calf-serum and 1% antibiotic/antimycotic (ABAM). For
induction of decidualization, ESC were treated with 0.5 mM 8-Br-
cAMP (Sigma) and 1 mM medroxyprogesterone acetate. At 80%
confluency, cells were transfected using TransIT-LT1 (Mirus, Cat.
No. MIR2304) according to the manufacturer’s protocol to
introduce the following vectors: for RNAi mediated silencing,
either of two HuSH 29mer shRNA plasmids expressing siRNA
directed against two different target sequences of human HoxA-11
mRNA (Origene, Cat. No. 312366) were employed; vehicle
control samples were transfected with a HuSH 29mer shRNA
plasmid expressing a non-targeting random sequence siRNA. For
overexpression and reporter gene studies, cells received expression
vectors for human HoxA-11, HoxA-10, FOXO1A and the
decidual PRL enhancer/promoter reporter constructs. Cells were
harvested and RNA collected 3 days after differentiation/
transfection.
Figure 6. Physical interaction between HoxA-11 and FOXO1A. HoxA-11-V5/His and Flag-FOXO1A were overexpressed in HeLa cells and
subjected to co-immunoprecipitation with anti-FLAG agarose beads. Eluates, without or with DNase treatment, were analyzed by Western blotting
with V5 antibody, followed by re-probing with FLAG antibody.
doi:10.1371/journal.pone.0006845.g006
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PCR Master Mix, and HoxA-11, PRL and GADPH endogenous
control primer/probe sets were purchased from Applied Biosys-
tems. Luciferase expression was measured using a TaqMan
Primer/Probe set designed to the luciferase gene in pGL3-Basic
reporter vector.
Co-Immunoprecipitation Assay
HeLa cells were cultured in Dulbecco’s modification of Eagle’s
medium (DMEM; Cellgro) with 4.5 g/L glucose and L-glutamine
and without sodium pyruvate, plus 5% fetal bovine serum (Gibco)
and 1x ABAM (Gibco). Prior to transfection, cells were plated at a
density of ,4.4610
6 cells/mL on 10 cm plates. The next day,
Hox-A11-V5/His construct was transfected into HeLa cells with
either empty pcDNA3.1(+) vector, or Flag-Foxo1A pcDNA3.1
vector using Lipofectamine 2000 (Invitrogen) per the manufac-
turer’s protocol. A total of 12 mg of DNA was mixed with
Lipofectamine (1:3) in 3 mL OptiMEM reduced serum media
(Gibco) and incubated for 4 hours at 37uC, before addition of
7 mL DMEM. After 16 hours the transfection media was removed
and replaced with fresh DMEM, and the cells were incubated an
additional 24 hours before harvesting.
After removing DMEM and washing cells twice with PBS,
1 mL ice-cold lysis buffer (20 mM Tris, pH 8.0, 40 mM KCl,
10 mM MgCl2, 10% glycerol, 1% Triton X-100, 1x Complete
EDTA-free protease inhibitor cocktail (Roche), 1x PhosSTOP
(Roche)) was added to each plate and cells were harvested by
scraping with a rubber spatula. Harvested cells were transferred
to borosilicate glass tubes, and incubated on ice for 10 minutes
prior to the addition of 5 M NaCl to a final concentration of
4 2 0 m M .C e l l sw e r es o n i c a t e di na nu l t r a s o n i cw a t e rb a t h
(Sonicor) for 2615 seconds, followed by an additional incubation
on ice for 60 minutes, and another round of sonication. Whole
cell lysate was cleared by centrifugation at 10,000 rpm for 30
minutes at 4uC, and supernatant was transferred to a clean
microfuge tube. Total protein concentration was determined by
Bradford analysis. After equilibrating protein concentrations,
1 mL of sample was mixed with 40 mL of M2 anti-FLAG agarose
beads (Sigma) pre-washed with TNT buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 0.05% Triton X-100), and rotated
o v e r n i g h ta t4 uC.
The following day, samples were treated with 50 U DNase
(Roche) and 2.5 mg RNase (Roche) for 60 minutes at room
temperature, as indicated. Samples were washed 3x with 1 mL of
Hepes Wash (10 mM Hepes, 150 mM NaCl, 0.5% Triton X-100).
Between each wash, agarose beads were collected by centrifuga-
tion at 1000 rpm for 1 min at 4uC and supernatant was removed.
After the final wash, beads were re-suspended in elution buffer
(500 mM Tris pH 7.5, 1 M NaCl), and incubated for 1 hour at
4uC. Agarose beads were pelleted at 5000 rpm for 1 min, and
supernatant was transferred to a clean tube containing loading
buffer (50 mM Tris pH 6.8, 100 nM DTT, 2% SDS, 0.1%
bromophenol blue, 10% glycerol) and resolved on a 12% SDS-
PAGE gel at 100 V. Proteins were transferred to a PVDF
membrane (100 V for 1.5 hours). After transfer, membrane was
blocked with TBS Tween20+BSA (25 mM Tris, 150 mM NaCl,
3% BSA), then incubated with anti-V5-HRP antibody (1:5000;
invitrogen) for 2 hours. Bands were visualized using the ECL
SuperSignal West Pico Chemiluminescent Substrate (Thermo
Scientific). Membranes were stripped with Restore Western Blot
stripping buffer (Thermo Scientific) and re-probed with anti-Flag-
HRP antibody (1:100,000; Sigma).
Figure 7. Chromatin immunoprecipitation assay for transcription factors at the dPRL enhancer. Chromatin immunoprecipiation was
performed in differentiated hESC with either a control IgG, or antibodies to FOXO1A, p300, Pol-II, C/EBPb, HoxA-11 or YY1. Results are shown as fold
enrichment over IgG (after normalization to inputs). n=6 replicate experiments, means6SEM. *, P,0.05; ***, P,0.001 (t-test compared to IgG).
doi:10.1371/journal.pone.0006845.g007
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For chromatin immunoprecipitation (ChIP), the EZ-Zyme
Chromatin Prep kit (Upstate Millipore, Billerica, MA) was used
following the manufacturer’s protocol. Briefly, crosslinking was
done on differentiated hESC with 1% formaldehyde, followed by
DNA fragmentation. The equivalent of 10
6 cells was used for each
immunoprecipitation. The nuclear lysate was precleared with
protein G magnetic beads and incubated over night at 4uC with
protein G magnetic beads, and 2 mg of either the antibodies
against FOXO1A, p300, Pol-II, CEBPb, HoxA-11 and Y11, or
with the rabbit IgG as negative control (all from Santa Cruz
Biotechnology, Santa Cruz, CA). Enrichment of the dPRL
enhancer was evaluated by qPCR using 1/50 of the immunopre-
cipitated chromatin as template and the Power SYBR Green PCR
Master Mix (Applied Biosystems, Foster City, CA).
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